Cocrystal Pharma Inc (COCP) 0.4690 $COCP Cocrystal

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cocrystal Pharma Inc (COCP) 0.4690 $COCP

Cocrystal Appoints Gary Wilcox as Interim Chief Executive Officer
Marketwire Canada - Fri Jul 22, 8:00AM CDT
BOTHELL, WA and ATLANTA, GA--(Marketwired - July 22, 2016) - Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, announced today that Dr. Gary Wilcox will assume the role of interim Chief Executive Officer effective July 22, 2016. Dr. Wilcox previously served as the Chief Executive Officer of Cocrystal from 2008 to 2015. Mr. Jeffrey Meckler stepped down as Chief Executive Officer and from the Board to pursue other interests. Dr. Wilcox will continue to serve as the Vice Chairman of the Board of Directors of the company. In addition, Dr. Douglas Mayers, the Chief Medical Officer at Cocrystal, submitted his resignation effective immediately. Dr. Luz Pascual, Vice President Clinical Development, shall continue to oversee the ongoing clinical programs.

Cocrystal Pharma to Present at Jefferies 2016 Healthcare Conference
Marketwired - Wed May 25, 7:01AM CDT
Cocrystal CEO & CMO to Present Thursday, June 9, 2016, 8:30 AM ET in NYC
OPK: 9.98 (+0.01)

Cocrystal Pharma Announces Filing 2016 First Quarter Financial Statements and Provides Company Update
Marketwired - Wed May 11, 6:30AM CDT
BOTHELL, WA and ATLANTA, GA--(Marketwired - May 11, 2016) - Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing of its financial statements for the quarter ending March 31, 2016 and provided an update on the Phase Ia/Ib clinical study of CC-31244.
OPK: 9.98 (+0.01)

Big Insider Moves at Majesco, Phillip Frost Discloses Major Insider Transaction
ACCESSWIRE - Mon May 09, 10:09AM CDT
NEW YORK, NY / ACCESSWIRE / May 9, 2016 / After picking up a new management team and additional board of directors, stagnant video gaming firm Majesco Entertainment Co. (NASDAQ:COOL) just landed key insider investments totalling 9.9% of shares outstanding as of May 9. Leading the aggressive accumulation is the legendary biotechnology investor Dr. Phillip Frost, CEO of Opko Health (NYSE:OPK) and former CEO of generics giant Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA).
YHOO: 38.59 (-0.17), COOL: 0.74 (-0.02), OPK: 9.98 (+0.01), CDXC: 3.98 (-0.02), TEVA: 54.63 (+0.32), MJCO: 5.50 (-0.01)

Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in Healthy and HCV-Infected Subjects
Marketwired - Mon Apr 25, 7:01AM CDT
Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, announced today that it has initiated a Phase Ia/Ib clinical study of CC-31244, a pan-genotypic, potent NS5B non-nucleoside inhibitor (NNI), for the treatment of chronic hepatitis C virus (HCV) infection. The study is currently enrolling subjects and has dosed the first subject with no serious adverse events reported.
OPK: 9.98 (+0.01)

Retrophin Names Gary A. Lyons Chairman of the Board of Directors
GlobeNewswire - Mon Apr 04, 3:30PM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced Gary A. Lyons will become the Company's next independent Chairman of the Board of Directors, effective at the conclusion of the annual meeting of stockholders, to be held on May 18, 2016. Mr. Lyons, an independent director of Retrophin since 2014, will succeed current Chairman Jeffrey A. Meckler. Mr. Meckler, who was appointed chief executive officer of Cocrystal Pharma, Inc. in October 2015, will remain on the Board as an independent director.
RTRX: 18.19 (+0.18)

CORRECTION - Cocrystal Pharma Reports Financial Results for Fourth Quarter & Year Ended December 31, 2015 and Provides Company Update
Marketwired - Wed Mar 16, 8:59AM CDT
In the news release, "Cocrystal Pharma Reports Financial Results for Fourth Quarter & Year Ended December 31, 2015 and Provides Company Update" issued Tuesday, March 15, 2016 by Cocrystal Pharma, Inc. (OTCQB: COCP), we are advised by the company that the fifth paragraph should now read "During the fourth quarter, General and Administrative (SG&A) cash expenses were $2.0 million for 2015 compared to $0.3 million for 2014. The increase of $1.7 million was due to compensation related costs, and professional service costs related to being a public company. In addition, the Company incurred non-cash charges related to stock options of $0.9 million." Complete corrected text follows.
OPK: 9.98 (+0.01)

Cocrystal Pharma Reports Financial Results for Fourth Quarter & Year Ended December 31, 2015 and Provides Company Update
Marketwired - Tue Mar 15, 4:47PM CDT
Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced the filing on Form 10-K of its financial results for the fourth quarter and year ended December 31, 2015, and provided a research and development update.
OPK: 9.98 (+0.01)

UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 3.90 (+0.08), DMPI: 7.18 (-0.17), CDXC: 3.98 (-0.02)

OTCQX And OTCQB Companies To Present At 2016 ROTH Conference
PR Newswire - Thu Mar 10, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 3.90 (+0.08), DMPI: 7.18 (-0.17), CDXC: 3.98 (-0.02)

Cocrystal Pharma to Present at Two Upcoming Investor Conferences
Marketwired - Wed Mar 09, 6:30AM CST
Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced that Jeffery Meckler, Chief Executive Officer, and Douglas Mayers, M.D., Chief Medical Officer, will present a corporate overview at the 28th Annual ROTH Conference and the Barclays Capital Global Healthcare Conference.
OPK: 9.98 (+0.01)

Cocrystal Pharma Announces In-Licensing of CRISPR Cas Technologies for Hepatitis B Virus and Human Papilloma Virus
Marketwired - Wed Feb 10, 7:02AM CST
Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, announced today it has signed an agreement with Duke University and Emory University to license various patents and know-how to use CRISPR/Cas9 technologies for developing a possible cure for hepatitis B virus (HBV) and human papilloma virus (HPV).
OPK: 9.98 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 154

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 65

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 22

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 17

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 146

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading

Top 5 Most Recently Viewed Articles

Actuate Therapeutics Achieves Notable Index Inclusion Milestone

Updated Category News Views 177

Actuate Therapeutics Celebrates Inclusion in Renowned Russell Indexes This recent inclusion exemplifies the rising momentum of Actuate Therapeutics, Inc. (NASDAQ: ACTU) as the company strives to innovate treatments for challenging cancers such as metastatic pancreatic ductal adenocarcinoma (mPDAC). The addition to the Russell 3000® Index and, by extension, the Russell...

Continue Reading
Insights on the Future Direction of Stora Enso's Leadership

Updated Category News Views 421

Proposals for Stora Enso Oyj's Board of Directors STORA ENSO OYJ STOCK EXCHANGE RELEASE - The Shareholders' Nomination Board has shared recommendations ahead of Stora Enso Oyj's upcoming Annual General Meeting. These proposals, made public well in advance, prepare the ground for a comprehensive evaluation of the company's leadership. The Board will ask for approval of its...

Continue Reading
Daisy Unveils Expansion Plans with NJ Smart Home Conversion

Updated Category News Views 200

Daisy Unveils Expansion Plans with NJ Smart Home Conversion Daisy franchisee brings expertise in advanced video walls and home entertainment systems Daisy, the fastest growing national home and small business technology installation and services company, is pleased to announce the conversion of NJ Smart Home & Theater into a franchise operation. This strategic move...

Continue Reading
You.com Partners with Boardwave to Revolutionize AI Productivity

Updated Category News Views 104

You.com and Boardwave Collaborate for AI Innovation You.com, an AI productivity platform, has recently announced an exciting partnership with Boardwave, a prominent network of over 1,700 software leaders across Europe. This collaboration aims to boost productivity and facilitate the integration of artificial intelligence throughout the European software landscape....

Continue Reading
Goldmoney Inc.'s Q3 Performance and Financial Restatement Update

Updated Category News Views 374

Financial Performance of Goldmoney Inc. Goldmoney Inc. (TSX: XAU) recently released its financial results for the fiscal 2025 third quarter, showcasing a robust performance despite challenges in the market. With all figures reported in Canadian dollars, the company evidenced strength through its tangible capital and efficient management of resources. Quarterly Financial...

Continue Reading